NEWARK, DE | The Microfluidic Organ-on-Chip Drug Testing Market is poised for rapid expansion, rising from USD 141.5 million in 2025 to USD 932.9 million by 2036, advancing at a CAGR of 18.70%. With the market valued at USD 168.0 million in 2026, the shift toward human-relevant, predictive preclinical models is redefining drug development workflows and accelerating the replacement of...
NEWARK, DE | 17 Mar 2026 — The photon-counting CT scanner technology market is valued at USD 0.4 billion in 2025 and is expected to reach USD 0.5 billion in 2026, advancing at a CAGR of 14.80% through 2036. With sustained financial commitments and rapid replacement of legacy detector systems, the market is projected to achieve USD 2.06 billion by 2036. The transition toward...
NEWARK, DE | The Microneedle Patch Influenza Vaccine Delivery Market is valued at USD 19.5 million in 2025 and is expected to reach USD 24.0 million in 2026, expanding at a CAGR of 23.00% through 2036. The market is projected to surge to USD 190.2 million by 2036, driven by the global shift from cold-chain dependent liquid vaccines to thermostable, self-administered patch-based...
NEWARK, DE |—The long-acting implantable GLP-1 obesity devices market is valued at USD 59.1 million in 2025 and is projected to reach USD 76.0 million in 2026. Expanding at a robust CAGR of 28.50%, the market is expected to surge to USD 932.9 million by 2036. This growth reflects a fundamental shift in obesity care delivery, as stakeholders prioritize long-term therapy...
NEWARK, DE | The patient monitoring system market was valued at USD 62.6 million in 2025. According to Future Market Insights (FMI), the global patient monitoring system market is projected to expand from USD 69.2 million in 2026 to USD 169.9 million by 2036, reflecting a steady compound annual growth rate (CAGR) of 9.4%. This structural expansion, delivering an absolute...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek